← FDA Drug Approvals (Drugs@FDA)

LACOSAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2022-09-26

Drug application

FDA Application #

ANDA206355

Application type

Abbreviated New Drug Application (Generic)

Brand name

LACOSAMIDE

Generic name

Lacosamide

Active ingredients

LACOSAMIDE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

APOTEX

First approval

2022-09-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown